期刊文献+

肿瘤基因组中体细胞性改变的研究进展

Progress in research on somatic alterations in the oncogenome
下载PDF
导出
摘要 大部分人类肿瘤是由基因组中的体细胞性改变所导致的癌基因激活或抑癌基因失活所引发的.本文总结了近年来肿瘤基因组中体细胞性改变的研究状况,我们主要关注人类基因组计划为肿瘤相关基因的鉴定所带来的机遇并讨论以全基因组分析为基础的研究进展. Somatic alterations within the oncogenome underlie the genesis and progression of most human tumors, by causing oncogene activation or tumor suppressor gene inactivation. The present review summarizes our current knowledge of these areas and the progress that has been made. The purposes of this review are to highlight the importance of the human genome project to identify cancer genome alterations, and to discuss the advancement of research on systematic cancer genome analysis.
出处 《世界华人消化杂志》 CAS 北大核心 2007年第28期3029-3034,共6页 World Chinese Journal of Digestology
基金 美国中华医学基金会(CMB)资助项目 No.04-805~~
关键词 肿瘤基因组 体细胞性改变 人类基因组计划 突变 Oncogenome Somatic alterations Hu-man genome project Mutation
  • 相关文献

参考文献46

  • 1Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232:1644-1646.
  • 2Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004; 4:177-183.
  • 3Knudson AG. Chasing the cancer demon. Annu Rev Genet 2000; 34: 1-19.
  • 4Knudson AG. Cancer genetics. Am J Med Genet 2002; 111:96-102.
  • 5Daley GQ, Ben-Neriah Y. Implicating the bcr/ abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia. Adv Cancer Res 1991; 57:151-184.
  • 6Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res 2000; 462:247-253.
  • 7Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-792.
  • 8Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152:1107-1123.
  • 9Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001; 10: 721-733.
  • 10Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-440.

二级参考文献16

  • 1Takashi U,Akira T,Shigefumi Y,Toshihiro A,Hiroaki T,Tomoko F,Shigeto K,Atsunori O,Masaaki O,Kohsuke S. Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2002; 8:526-533
  • 2Yen CC, Chen YJ,Chen JT, Hsia JY,Chen PM, Liu JH, Fan F S,Chiou TJ,Wang WS,Lin CH. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis.Cancer 2001;92:2769-2777
  • 3Petersen I,Langreck H,Wolf G, Schwendel A,Psille R,Vogt P,Reichel MB,Ried T,Dietel M. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3q,4q,5q,10q,13q and17. Br J Cancer 1997;75:79-86
  • 4El Rifai W,Frierson HF Jr,Moskaluk CA,Harper JC, Petroni GR,Bissonette EA, Jones DR, Knuutila S,Powell SM. Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology 2001;121:592-598
  • 5Tada K,Oka M,Hayashi H,Tangoku A,Oga A,Sasaki K. Cytogenetic analysis of esophageal squamous cell carcinoma cell lines by comparative genomic hybridization: relationship of cytogenetic aberrations to in vitro cell growth. Cancer Genet Cytogenet 2000;117:108-112
  • 6Tada K,Oka M,Tangoku A,Hayashi H, Oga A, Sasaki K. Gains of 8q23-qter and 20q and loss of 11q22-qter in esophageal squamous cell carcinoma associated with lymph node metastasis. Cancer 2000;88:268-273
  • 7Bektas N,Donner A,Wirtz C,Heep H,Gabbert H E,Sarbia M.Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett's esophagus. Am J Clin Pathol 2000;114:890-895
  • 8Werner M,Walch A. Morphologie and biologie der invasion am beispiel des barrett-karzinoms. [Morphology and biology of invasion with Barret's carcinoma as an example]. Verh Dtsch Ges Pathol 2000;84:62-68
  • 9Dolan K, Garde J,Walker S J,Sutton R,Gosney J,Field J K. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Hum Pathol 1999;30:1508-1514
  • 10Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS,Bredesen DE.The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998;395:801-804

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部